New York State Common Retirement Fund
RNTX

New York State Common Retirement Fund’s Rein Therapeutics RNTX Stock Holding History

New York State Common Retirement Fund’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50
Closed -$8K – 3223
2018
Q1 		$8K Hold
50
– – ﹤0.01% 3075
2017
Q4 		$11K Buy
+50
New +$12K ﹤0.01% 3075

Other funds holding RNTX

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund's RNTX Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Rein Therapeutics (RNTX) in Q2 2018, closing a stake of 50 shares — an estimated $8K sold.

New York State Common Retirement Fund first reported a position in RNTX in Q4 2017 and held it in 2 quarters. The position peaked at $11K in Q4 2017. 20 funds tracked by Wall St. Rank hold RNTX as of Q2 2018.

  • New York State Common Retirement Fund reported no remaining Rein Therapeutics position as of Q2 2018 after selling out during the quarter.
  • New York State Common Retirement Fund sold 50 Rein Therapeutics shares in Q2 2018, an estimated $8K.
  • New York State Common Retirement Fund first reported a position in Rein Therapeutics in Q4 2017 and held it in 2 quarters.
  • New York State Common Retirement Fund's Rein Therapeutics position peaked at $11K in Q4 2017.
  • 20 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.